CD80 and ovarian carcinoma: ACOD1-/- MSLN-CAR-iMACs expressed more pro-inflammatory marker proteins (CD80 and CD86) after being co-cultured with HO-8910 ovarian cancer cells for 24 h (Fig. 6a, b).